Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 36, 2022 - Issue 7
160
Views
7
CrossRef citations to date
0
Altmetric
Short Communications

Linderolide U, a new sesquiterpene from Lindera aggregata root

, &
Pages 1914-1918 | Received 05 Jul 2020, Accepted 25 Aug 2020, Published online: 14 Sep 2020

References

  • Bensky D, Gamble A, Kaptchuk T. 1986. Chinese herbal medicine: materia medica. Seattle, USA: Eastland Press; p. 341.
  • Chang W-A, Lin E-S, Tsai M-J, Huang M-S, Kuo P-L. 2014. Isolinderalactone inhibits proliferation of A549 human non‑small cell lung cancer cells by arresting the cell cycle at the G0/G1 phase and inducing a Fas receptor and soluble Fas ligand-mediated apoptotic pathway. Mol Med Rep. 9(5):1653–1659.
  • Gan L-S, Zheng Y-L, Mo J-X, Liu X, Li X-H, Zhou C-X. 2009. Sesquiterpene Lactones from the Root Tubers of Lindera aggregata. J Nat Prod. 72(8):1497–1501.
  • Kobayashi W, Miyase T, Sano M, Umehara K, Warashina T, Noguchi H. 2002. Prolyl Endopeptidase Inhibitors from the Roots of Lindera strychnifolia F. VILL. Biol Pharm Bull. 25(8):1049–1052.
  • Kouno I, Hirai A, Fukushige A, Jiang Z-H, Tanaka T. 2001. New eudesmane sesquiterpenes from the root of Lindera strychnifolia. J Nat Prod. 64(3):286–288.
  • Li W-S, Duh C-Y. 1993. Sesquiterpene lactones from Neolitsea villosa. Phytochemistry. 32(6):1503–1507.
  • Li B, Jeong G-S, Kang D-G, Lee H-S, Kim Y-C. 2009. Cytoprotective effects of lindenenyl acetate isolated from Lindera strychnifolia on mouse hippocampal HT22 cells. Eur J Pharmacol. 614(1–3):58–65.
  • Liu Q, Ahn JH, Kim SB, Lee C, Hwang BY, Lee MK. 2013. Sesquiterpene lactones from the roots of Lindera strychnifolia. Phytochemistry. 87:112–118.
  • Noda Y, Mori A. 2007. Antioxidant activities of uyaku (Lindera Strychnifolia) leaf extract: a natural extract used in traditional medicine. J Clin Biochem Nutr. 41(2):139–145.
  • Ohno T, Nagatsu A, Nakagawa M, Inoue M, Li Y-M, Minatoguchi S, Mizukami H, Fujiwara H. 2005. New sesquiterpene lactones from water extract of the root of Lindera strychnifolia with cytotoxicity against the human small cell lung cancer cell, SBC-3. Tetrahedron Lett. 46(50):8657–8660.
  • Ohno T, Takemura G, Murata I, Kagawa T, Akao S, Minatoguchi S, Fujiwara T, Fujiwara H. 2005. Water extract of the root of Lindera strychnifolia slows down the progression of diabetic nephropathy in db/db mice. Life Sci. 77(12):1391–1403.
  • Sumioka H, Harinantenaina L, Matsunami K, Otsuka H, Kawahata M, Yamaguchi K. 2011. Linderolides A-F, eudesmane-type sesquiterpene lactones and linderoline, a germacrane-type sesquiterpene from the roots of Lindera strychnifolia and their inhibitory activity on NO production in RAW 264.7 cells in vitro. Phytochemistry. 72(17):2165–2171.
  • Sun Q, Sun A, Liu R. 2006. Preparative Isolation and Purification of Linderalactone and Lindenenol from Radix linderae by HSCCC. J Liq Chromatogr Relat Technol. 29(1):113–121.
  • Tada H, Minato H, Takeda K. 1971. Components of the root of Lindera strychnifolia Vill. Part XVIII. Neosericenyl acetate and dehydrolindestrenolide. J Chem Soc C.:1070–1073.
  • Tori K, Ueyama M, Horibe l, Tamura Y, Takeda K. 1975. Carbon-13 nmr spectra of some furanosesquiterpenes, major components of Lindera strychnifolia. Tetrahedron Lett. 16(51):4583–4586.
  • Wu S-L, Li W-S. 1991. Terpenoids from Neolitsea buisanensis. Phytochemistry. 30(12):4160–4162.
  • Yan R, Yang Y, Zeng Y, Zou G. 2009. Cytotoxicity and antibacterial activity of Lindera strychnifolia essential oils and extracts. J Ethnopharmacol. 121(3):451–455.
  • Zhang C-f, Nakamura N, Tewtrakul S, Hattori M, Sun Q-s, Wang Z-t, Fujiwara T. 2002. Sesquiterpenes and alkaloids from Lindera chunii and their inhibitory activities against HIV-1 integrase. Chem Pharm Bull. 50(9):1195–1200.
  • Zhao Y, Hu X, Zuo X, Wang M. 2018. Chemopreventive effects of some popular phytochemicals on human colon cancer: a review. Food Funct. 9(9):4548–4568.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.